Clinical trial · Observational
Complete Clinical Responders to Definite Chemoradiation in Esophageal Cancer : a Survival Analysis
Predictors of Survival for Complete Clinical Responders to Definite Chemoradiation or Radiation Therapy for Esophageal Cancer
NCT01525953CI-TRIAL-00006197CRCRT-ECcompletedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of this study is to identify prognostic factors for outcome in patients being complete clinical responders with chemoradiation or radiation for esophageal cancer
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Esophageal Cancer | Malignant Esophageal Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Chemotherapy | Drug | Chemotherapy | ALIAS |
| Radiotherapy | Radiation | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Identification of prognostic factors for overall survival
- timeFrame
- From date of treatment until death, assessed up to 10 years
- description
- Correlation between survival and baseline,clinical and treatment characteristics
Secondary outcomes (2)
- measure
- Patterns of treatment failure
- timeFrame
- From date of treatment until treatment failure, assessed up to 10 years
- description
- Type of recurrence : local, regional, distant.
- measure
- Disease-free survival
- timeFrame
- From date of treatment until progression or death, assessed up to 10 years
- description
- Time between the end of treatment and the occurence of progression
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * localized or locally advanced esophageal cancer * patient who underwent definite chemoradiation or radiation * patient with complete clinical response Exclusion Criteria: * metastatic disease
References
Publications (0)
Data not yet available
No reference posted for this study.